PALISADE BIO, INC.
PALIDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 10, 2026
5wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How PALI's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
LB1148 | Phase 2 | Ileus | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in PALISADE BIO, INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in PALISADE BIO, INC.'s (PALI) pipeline across Phase 2. Its lead program is LB1148 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PALISADE BIO, INC.'s next FDA catalyst?→
PALISADE BIO, INC.'s (PALI) next tracked catalyst is a Earnings expected August 10, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track PALI biotech catalysts?→
Add PALI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PALISADE BIO, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.